Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bernhard Scheiner

Showing results (21-30 of 203) with videos related to

Pageof 21
Sort By:
Alimentary Pharmacology & Therapeutics|August 28, 2020
Letter: sequential or combined systemic treatment for unresectable hepatocellular carcinoma-authors' replyMartha M Kirstein, Bernhard Scheiner, Matthias Pinter, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|November 14, 2022
Reply to comment: Von Willebrand factor measurement during acute decompensationMattias Mandorfer, Katharina Pomej, Bernhard Scheiner, et al.
Gut|April 29, 2025
Systemic treatment in patients with hepatocellular carcinoma and advanced liver dysfunctionMatthias Pinter, Claudia A M Fulgenzi, David J Pinato, et al.
Journal of Hepatology|July 8, 2017
Acid-base disorders in liver diseaseBernhard Scheiner, Gregor Lindner, Thomas Reiberger, et al.
United European Gastroenterology Journal|August 4, 2020
Alpha-fetoprotein-adjusted-to-HCC-size criteria are associated with favourable survival after liver transplantation for hepatocellular carcinomaTobias Meischl, Susanne Rasoul-Rockenschaub, Georg Győri, et al.
Plos One|April 7, 2023
Early changes in immunoglobulin G levels during immune checkpoint inhibitor treatment are associated with survival in hepatocellular carcinoma patientsLorenz Balcar, David Bauer, Katharina Pomej, et al.
Wiener Klinische Wochenschrift|September 8, 2019
Patterns and prevalence of dyslipidemia in patients with different etiologies of chronic liver diseaseLukas W Unger, Bernadette Forstner, Stephan Schneglberger, et al.
Plos One|August 26, 2021
COVID-19 pandemic: Impact on the management of patients with hepatocellular carcinoma at a tertiary care hospitalKatharina Pomej, Bernhard Scheiner, Lukas Hartl, et al.
Scientific Reports|May 17, 2024
Use of the CytoSorb adsorber in patients with acute-on-chronic liver failurePatrick Haselwanter, Bernhard Scheiner, Lorenz Balcar, et al.
Cancer Imaging : the Official Publication of the International Cancer Imaging Society|January 12, 2024
Management of varices but not anticoagulation is associated with improved outcome in patients with HCC and macrovascular tumour invasionLorenz Balcar, Arpad Mrekva, Bernhard Scheiner, et al.
Pageof 21

Showing results (21-30 of 203) with videos related to

Sort By:
Pageof 21
Alimentary Pharmacology & Therapeutics|August 28, 2020
Letter: sequential or combined systemic treatment for unresectable hepatocellular carcinoma-authors' replyMartha M Kirstein, Bernhard Scheiner, Matthias Pinter, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|November 14, 2022
Reply to comment: Von Willebrand factor measurement during acute decompensationMattias Mandorfer, Katharina Pomej, Bernhard Scheiner, et al.
Gut|April 29, 2025
Systemic treatment in patients with hepatocellular carcinoma and advanced liver dysfunctionMatthias Pinter, Claudia A M Fulgenzi, David J Pinato, et al.
Journal of Hepatology|July 8, 2017
Acid-base disorders in liver diseaseBernhard Scheiner, Gregor Lindner, Thomas Reiberger, et al.
United European Gastroenterology Journal|August 4, 2020
Alpha-fetoprotein-adjusted-to-HCC-size criteria are associated with favourable survival after liver transplantation for hepatocellular carcinomaTobias Meischl, Susanne Rasoul-Rockenschaub, Georg Győri, et al.
Plos One|April 7, 2023
Early changes in immunoglobulin G levels during immune checkpoint inhibitor treatment are associated with survival in hepatocellular carcinoma patientsLorenz Balcar, David Bauer, Katharina Pomej, et al.
Wiener Klinische Wochenschrift|September 8, 2019
Patterns and prevalence of dyslipidemia in patients with different etiologies of chronic liver diseaseLukas W Unger, Bernadette Forstner, Stephan Schneglberger, et al.
Plos One|August 26, 2021
COVID-19 pandemic: Impact on the management of patients with hepatocellular carcinoma at a tertiary care hospitalKatharina Pomej, Bernhard Scheiner, Lukas Hartl, et al.
Scientific Reports|May 17, 2024
Use of the CytoSorb adsorber in patients with acute-on-chronic liver failurePatrick Haselwanter, Bernhard Scheiner, Lorenz Balcar, et al.
Cancer Imaging : the Official Publication of the International Cancer Imaging Society|January 12, 2024
Management of varices but not anticoagulation is associated with improved outcome in patients with HCC and macrovascular tumour invasionLorenz Balcar, Arpad Mrekva, Bernhard Scheiner, et al.
Pageof 21